Showing results (21-30 of 57) with videos related to
Sort By:
Pageof 6
International Journal of Cancer|September 4, 1995
Low-dose IL-2 treatment: activation of discrete T- and NK-cell sub-populations in vivoF Farace, E Angevin, P Y Dietrich, et al.Journal of Biological Response Modifiers|December 1, 1990
Immunotherapy with lymphokine-activated natural killer cells and recombinant interleukin-2: a feasibility trial in metastatic renal cell carcinomaT Hercend, F Farace, D Baume, et al.Surgical and Radiologic Anatomy : SRA|June 5, 2013
A new contrast agent for radiological and dissection studies of the arterial network of anatomic specimensA Bulla, C Casoli, F Farace, et al.Annals of Plastic Surgery|February 24, 2001
Ultrastructural anatomy of contracted capsules around textured implants in augmented breastsC Rubino, V Mazzarello, F Farace, et al.European Review for Medical and Pharmacological Sciences|June 20, 2014
A simple and cheap system to speed up and to control the tumescent technique procedure: the Tedde's systemC Rubino, F Marongiu, M J Manzo, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|October 1, 1995
Phase I study of prolonged low-dose subcutaneous recombinant interleukin-2 (IL-2) in patients with advanced cancerE Angevin, D Valteau-Couanet, F Farace, et al.Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy|July 1, 1994
T-cell receptor repertoire in colorectal adenocarcinoma patients with hepatic metastases and its changes induced by preoperative adjuvant interleukin-2 therapyE Savelieva, F Farace, E Angevin, et al.International Journal of Cancer|June 11, 1997
T-cell receptor CDR3 size distribution analysis to evaluate specific T-cell response to cancer vaccinesF Farace, E Angevin, I Poullion, et al.International Immunology|October 1, 1994
Influence of human leukocyte antigen genes on TCR V gene segment frequenciesC Genevée, F Farace, V Chung, et al.International Journal of Cancer|July 9, 1993
Influence of interleukin-2 administration on the expression of T-cell receptor V gene segments in patients with renal-cell carcinomaF Farace, E Angevin, B Escudier, et al.Pageof 6